Back
  1. Home
  2. Profile of Marianne Lecomte (ULiège)
Profil

Lecomte Marianne

See author's contact details
Main Referenced Co-authors
Darcis, Gilles  (6)
Frippiat, Frédéric  (6)
Léonard, Philippe  (6)
Meuris, Christelle  (6)
Moutschen, Michel  (6)
Main Referenced Keywords
HIV (2); Alanine (1); Anti-HIV Agents/adverse effects (1); antiretroviral therapy (1); Cardiovascular Diseases (1);
Main Referenced Unit & Research Centers
CHU de Liège, service de neurologie (1)
Main Referenced Disciplines
Immunology & infectious disease (6)
Neurology (1)

Publications (total 7)

The most downloaded
3914 downloads
DEPIERREUX, F., FANIELLE, J., Lecomte, M., HANS, G., MAQUET, P., & POIRRIER, R. (2014). La Narcolepsie-Cataplexie aujourd'hui. Revue Médicale de Liège, 69 (2), 72-81. https://hdl.handle.net/2268/160652

The most cited

30 citations (Scopus®)

DARCIS, G., Lambert, I., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., GIOT, J.-B., fombellida, K., VAIRA, D., & MOUTSCHEN, M. (2018). Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017. Scientific Reports. doi:10.1038/s41598-018-26852-0 https://hdl.handle.net/2268/226822

Plum, P.-E., Maes, N., Sauvage, A.-S., Frippiat, F., Meuris, C., Uurlings, F., Lecomte, M., Léonard, P., Paquot, N., Fombellida, K., Vaira, D., Moutschen, M., & Darcis, G. (2021). Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV. BMC Infectious Diseases, 21 (1), 910. doi:10.1186/s12879-021-06479-9
Peer Reviewed verified by ORBi

El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., Moutschen, M., & Darcis, G. (2020). Evolution of Drug Interactions With Antiretroviral Medication in People With HIV. Open Forum Infectious Diseases, 7 (11), 416. doi:10.1093/ofid/ofaa416
Peer Reviewed verified by ORBi

El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., FOMBELLIDA, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (22 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Poster presentation]. 8th BREACH SYMPOSIUM, Liège, Belgium.

El Moussaoui, M., Lambert, I., MAES, N., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., Fombellida, K., VAIRA, D., Vercheval, C., MOUTSCHEN, M., & DARCIS, G. (08 November 2019). Evolution of drug interactions with antiretroviral medications in HIV-infected patients [Paper presentation]. 17th European AIDS Conference, Bâle, Switzerland.

DARCIS, G., MAES, N., Pasternak, A., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., El Moussaoui, M., Fombellida, K., VAIRA, D.* , & MOUTSCHEN, M.*. (2019). Detectability of HIV residual Viremia despite therapy is highly associated with treatment with a protease inhibitor-based combination antiretroviral therapy. Antimicrobial Agents and Chemotherapy. doi:10.1128/AAC.01902-19
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

DARCIS, G., Lambert, I., SAUVAGE, A.-S., FRIPPIAT, F., MEURIS, C., UURLINGS, F., LECOMTE, M., LEONARD, P., GIOT, J.-B., fombellida, K., VAIRA, D., & MOUTSCHEN, M. (2018). Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017. Scientific Reports. doi:10.1038/s41598-018-26852-0
Peer Reviewed verified by ORBi

DEPIERREUX, F., FANIELLE, J., Lecomte, M., HANS, G., MAQUET, P., & POIRRIER, R. (2014). La Narcolepsie-Cataplexie aujourd'hui. Revue Médicale de Liège, 69 (2), 72-81.
Peer reviewed

Contact ORBi